Research Diagnosis Related Groups (DRG) level mortality quality outcomes for New York-Presbyterian Brooklyn Methodist Hospital located at 506 6Th St, Brooklyn, NY, 11215 & includes data from NPIs 1427025352, 1548374549, 1497863740, 1003928144
Dexur analyzed Q3 2018 (July to September 2018) Medicare claims data to benchmark mortality rates for New York-Presbyterian Brooklyn Methodist Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Jul 2018 to Sep 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 1,991 | 1,895 | ||||||||||||||||||||||
| Surgical | 462 | 450 | ||||||||||||||||||||||
| Non Surgical | 1,529 | 1,445 | ||||||||||||||||||||||
| Cardiovascular | 431 | 416 | ||||||||||||||||||||||
| General Medicine | 339 | 312 | ||||||||||||||||||||||
| Gastroenterology & Endocrinology | 194 | 189 | ||||||||||||||||||||||
| Neurology | 181 | 169 | ||||||||||||||||||||||
| Orthopedics | 166 | 162 | ||||||||||||||||||||||
| Urology | 162 | 158 | ||||||||||||||||||||||
| General Surgery | 161 | 154 | ||||||||||||||||||||||
| Pulmonology | 130 | 126 | ||||||||||||||||||||||
| Oncology & Hematology | 96 | 84 | ||||||||||||||||||||||
| Psychiatry & Mental Disorders | 72 | 68 | ||||||||||||||||||||||
| Colorectal | 21 | 21 | ||||||||||||||||||||||
| Obstetrics & Gynecology | 16 | 16 |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Jul 2018 to Sep 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Syncope And Collapse | ||||||||||||||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||||||||||||||
| Peripheral Vascular Disorders | ||||||||||||||||||||||||
| DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Hypertension | ||||||||||||||||||||||||
| Cardiac Pacemaker Revision Except Device Replacement | ||||||||||||||||||||||||
| Other Vascular Procedures | ||||||||||||||||||||||||
| DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Permanent Cardiac Pacemaker Implant | ||||||||||||||||||||||||
| Acute Myocardial Infarction | ||||||||||||||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||||||||||||||
| Percutaneous Intracardiac Procedures | ||||||||||||||||||||||||
| Other Circulatory O.R. Procedures | ||||||||||||||||||||||||
| DRG 264: OTHER CIRCULATORY SYSTEM O.R. PROCEDURES | ||||||||||||||||||||||||
| Chest Pain | ||||||||||||||||||||||||
| DRG 313: CHEST PAIN |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Jul 2018 to Sep 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 870: SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | ||||||||||||||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Cellulitis | ||||||||||||||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Signs And Symptoms | ||||||||||||||||||||||||
| DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Rehabilitation | ||||||||||||||||||||||||
| DRG 945: REHABILITATION WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Poisoning And Toxic Effects Of Drugs |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Jul 2018 to Sep 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Diabetes | ||||||||||||||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| G.I.Hemorrhage | ||||||||||||||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Digestive System Diagnoses | ||||||||||||||||||||||||
| DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Disorders Of Biliary Tract | ||||||||||||||||||||||||
| G.I. Obstruction |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Jul 2018 to Sep 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Degenerative Nervous System Disorders | ||||||||||||||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 056: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||||||||||||||
| Cranial And Peripheral Nerve Disorders | ||||||||||||||||||||||||
| DRG 074: CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Transient Ischemia | ||||||||||||||||||||||||
| DRG 069: TRANSIENT ISCHEMIA | ||||||||||||||||||||||||
| Seizures |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Jul 2018 to Sep 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Medical Back Problems | ||||||||||||||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Aftercare, Musculoskeletal System And Connective Tissue |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Jul 2018 to Sep 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidney And Urinary Tract Infections | ||||||||||||||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Renal Failure | ||||||||||||||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Jul 2018 to Sep 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||||||||||||||
| Peripheral And Cranial Nerve And Other Nervous System Procedures | ||||||||||||||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Jul 2018 to Sep 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||||||||||||||
| DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||||||||||||||
| Other Respiratory System Diagnoses | ||||||||||||||||||||||||
| Bronchitis And Asthma |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Jul 2018 to Sep 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Respiratory Neoplasms |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Jul 2018 to Sep 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||||||||||||||
| DRG 885: PSYCHOSES |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Jul 2018 to Sep 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures |